Catalyst Wire Dossier Catalyst Wire Dossier

XPOVIO (selinexor)

selinexor · Karyopharm Therapeutics Inc
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for XPOVIO (selinexor), covering 2016-05-16 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Karyopharm Expanded Access Program for Selinexor

See pricing